drugset / Trial / NCT00494429
Optimizing the Use of Morphine in Pre-Term Neonates
Phase 2
Completed
33 enrolled
John van den Anker
Erasmus Medical Center · collabUniversity of Louisville · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to improve the dosing of morphine in critically ill premature neonates.
Timeline
- Start
- 2005-05
- Primary completion
- 2014-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Morphine | Other / unclassified | 0.005 mg/kg | Intravenous |
| Subject | Morphine | Other / unclassified | 0.01 mg/kg | Intravenous |
Indications
No indication recorded.